Esclerosis Múltiple
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Ruberto S, Dominguez-Mozo MI, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Casanova-Peño I, González-Suárez I, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.
HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis.
Frontiers in Immunology . 17: 1776117-1776117.
-
Benito-León J, Díez-Cirarda M, Ruiz-Ortiz M, Aladro Y, Cuevas C, Domingo-Santos Á, Galán Sánchez-Seco V, Labiano-Fontcuberta A, Gómez-López A, Salgado-Cámara P, Costa-Frossard L, Monreal E, Sainz de la Maza S, Matías-Guiu J, Montero-Escribano P, Martínez-Ginés ML, Ayuso-Peralta L, Matías-Guiu JA.
Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing-Remitting Multiple Sclerosis.
Journal of Clinical Medicine . 15(6): .
-
Gonzalez-Gay MÁ, Gómez-Bernal F, Tejera-Segura B, Quevedo-Abeledo JC, García-Barrera E, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.
Serum IL-2 levels are associated with disease activity and related to dyslipidaemia and the immunological profile in systemic lupus erythematosus.
Lupus Science & Medicine . 13(1): .
-
Gómez-Bernal F, Quevedo Abeledo JC, Almeida-Santiago C, Fernández-Cladera Y, García-Barrera E, Villar LM, Largo R, Ocejo-Vinyals JG, González-Gay MÁ, Ferraz-Amaro I.
Clinical and serological associations of interferon-a and interferon-? in rheumatoid arthritis patients.
RHEUMATOLOGY . 65(2): . Nº de citas: 1
-
Comabella M, Gutierrez L, Castillo M, Villar LM, Eixarch H, La Puma D, Aroca M, Vilaseca A, Montalban X, Fissolo N.
Impact of preanalytical factors on blood CHI3L1 levels.
Frontiers in Immunology . 16: 1720914-1720914. Nº de citas: 1
-
Fissolo N, Benkert P, Vilaseca-Jolonch A, Blanco Y, Hegen H, Berek K, Pérez-Miralles F, Rejdak K, Villar L, Monreal E, Alvarez-Lafuente R, Bachhuber F, Tumani H, Martínez-Yelamos S, Sánchez-López A, García-Merino A, Gutiérrez L, Castillo-Triviño T, Lycke J, Rosenstein I, Téllez N, Furlan R, Lünemann JD, Khalil M, Kuhle J, Montalban X, Comabella M.
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.
EUROPEAN JOURNAL OF NEUROLOGY . 33(2): . Nº de citas: 1
-
Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A.
XVII Reunión Post-ECTRIMS: Revisión de las Novedades Presentadas en el Congreso ECTRIMS 2024 (Parte I).
REVISTA DE NEUROLOGIA . 81(1): 39227-39227.
-
Fernández Ó, Arés A, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Caminero AB, Castillo-Triviño T, Costa-Frossard L, Eichau S, Hernández MÁ, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Oreja-Guevara C, Prieto JM, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A.
XVII Reunión Post-ECTRIMS: Revisión de las Novedades Presentadas en el Congreso ECTRIMS 2024 (Parte II).
REVISTA DE NEUROLOGIA . 81(1): 39228-39228.
-
García de la Torre I, García-Hoz C, Martin-Moro F, Fernández-Velasco JI, Velázquez-Kennedy K, Rodríguez-Martín E, Luna De Abia A, Roldán E, Moreno Jiménez G, López-Jiménez J, Villar LM, Pariente-Rodríguez R.
Apheresis CD8(+)CCR7(+)CD45RA(-) T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(2): . Nº de citas: 1
-
Martín-Pedraza L, Rodríguez-Martín E, De La Torre-Tarazona E, Moreno E, Pariente-Rodríguez R, Walo-Delgado PE, García-Pérez J, Díaz J, Luna L, Rodríguez-Dominguez M, Galán JC, Geraldine Rita C, Del Amo-de Palacios A, Navarro-Soler R, Fons M, Alcamí J, Moreno S, Villar LM, Serrano-Villar S.
Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics.
Frontiers in Immunology . 16: 1693903-1693903.
-
Domínguez-Ruiz M, Chico JL, López-Marín L, Stanescu S, Crujeiras P, Rodrigues D, Heras-Alonso ML, Torremocha R, Meijón-Ortigueira MDM, Muñoz-Díez P, Lanza VF, Colón C, Villarrubia J, Belanger A, Castillo FJD.
Abnormal Splicing of GALC Transcripts Underlies Unusual Cases of Krabbe Disease
Biomedicines . 13(12): .
-
Landete L, Gómez-Ballesteros R, Meca-Lallana V, Caminero AB, Meca-Lallana JE, Martínez-Yélamos S, García-Domínguez JM, Agüera E, García-Arcelay E, Medrano N, Villar LM, Monreal E, Maurino J.
How do neurologists perceive the organization and functioning of multiple sclerosis care units?
Multiple Sclerosis Journal-Experimental Translational and Clinical . 11(4): . Nº de citas: 1
-
González-Gay MÁ, Gómez-Bernal F, Quevedo-Abeledo JC, Almeida-Santiago C, Heras-Recuero E, Torres-Roselló A, de Vera-González A, Tejera-Segura B, García-Barrera E, Blázquez-Sánchez T, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.
Ultrasensitive quantification of serum IFN-a and IFN-? in systemic lupus erythematosus: A cross-sectional observational study
PLOS MEDICINE . 22(12): . Nº de citas: 5
-
Rodero-Romero A, Domínguez-Mozo M, Monreal E, García-Domínguez JM, Villarrubia N, Fernández-Velasco JI, Comabella M, de la Maza SS, Goicochea Briceño H, Chico-García JL, García-Martínez MÁ, Rodriguez-Jorge F, Veiga-Gonzalez JL, Sainz-Amo R, Martínez Ginés ML, Montalban X, Masjuan J, Costa-Frossard L, Álvarez-Lafuente R, Villar LM.
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis
Frontiers in Immunology . 16: 1729500-1729500. Nº de citas: 2
-
González-Gay MÁ, Gómez-Bernal F, Heras-Recuero E, Quevedo-Abeledo JC, De Vera-González A, Tejera-Segura B, Gómez-Moreno C, García-Barrera E, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.
Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . : .
-
Keller CW, Stein K, Vilaseca A, Villar LM, Álvarez-Bravo G, Protopapa M, Shin J, Fissolo N, Martínez-Rodríguez JE, Quiroga-Varela A, García-Sarreón A, Gutiérrez L, Midaglia L, Montalban X, Lünemann JD, Comabella M.
Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome
Frontiers in Immunology . 16: 1680233-1680233.
-
Muñoz-Reyes D, Aguado L, Arroyo-Urea S, Requena C, Pérez-Suárez S, Sánchez-Yepes S, Argerich J, Miró-Rodríguez C, Ulzurrun E, Rodríguez-Martín E, García-Nafría J, Campillo NE, Mansilla A, Sánchez-Barrena MJ.
FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction
JOURNAL OF MEDICINAL CHEMISTRY . 68(22): 23993-24010. Nº de citas: 2
-
Torres Iglesias G, Chavarría-Miranda A, López-Molina M, Del Fresno C, Mata-Martínez P, Nozal P, Chico-Garcia JL, Fernández-Fournier M, Lacruz Ballester L, Sanchez D, Montero-Calle A, Barderas R, Bravo S, Puertas I, York E, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L.
Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes
Neurology-Neuroimmunology & Neuroinflammation . 12(6): .